Price Alert

DaVita Inc. (DVA)

NYSE: DVA · Real-Time Price · USD

134.48

-0.21 (-0.16%)

At close: Aug 14, 2025, 3:59 PM

136.18

1.26%

After-hours: Aug 14, 2025, 06:40 PM EDT

-0.16% (1D)

Bid	131.33
Market Cap	9.62B
Revenue (ttm)	13.16B
Net Income (ttm)	836.27M
EPS (ttm)	10.14
PE Ratio (ttm)	13.26
Forward PE	10.22
Analyst	Hold

Ask	137.19
Volume	546,222
Avg. Volume (20D)	835,925
Open	133.84
Previous Close	134.69
Day's Range	132.86 - 134.84
52-Week Range	126.07 - 179.60
Beta	1.09

About DVA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DVA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DVA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

DaVita has released their quartely earnings on Aug 5, 2025:

Revenue of $3.38B exceeds estimates by $25.69M, with 6.05% YoY growth.

EPS of 2.95 exceeds estimates by 0.22, with 13.90% YoY growth.

Next Earnings Release

DaVita Inc. is scheduled to release its earnings on Oct 28, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-9.04%

DaVita shares are trading lower. The company repor... Unlock content with Pro Subscription

6 months ago

-11.09%

DaVita shares are trading lower after the company reported Q4 financial results.

News

2 days ago · zacks.com

Here's Why DaVita HealthCare (DVA) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

3 days ago · zacks.com

Are Investors Undervaluing DaVita (DVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 week ago · zacks.com

DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands

DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.

1 week ago · seekingalpha.com

DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript

DaVita Inc. (NYSE:DVA ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Javier J. Rodriguez - CEO & Executive Director Joel Ackerman - CFO & Treasurer Nic Eliason - Gro...

1 week ago · zacks.com

DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates

DaVita HealthCare (DVA) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.7 per share. This compares to earnings of $2.59 per share a year ago.

1 week ago · reuters.com

DaVita beats quarterly profit on steady demand for dialysis services

DaVita beat Wall Street estimates for second-quarter profit on Tuesday, driven by demand for its kidney dialysis services.

2 weeks ago · zacks.com

DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note

DaVita HealthCare (DVA) closed the most recent trading day at $140.37, moving 2.91% from the previous trading session.

2 weeks ago · zacks.com

Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?

DVA rides early momentum from phosphate binders ahead of second-quarter 2025 earnings, but PD supply issues may cloud growth.

2 weeks ago · zacks.com

DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings Growth

DaVita HealthCare (DVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago · zacks.com

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Load More News